Nebraska Congressional Bills

in committee · Nebraska · House May 26, 2021

HRES 436: Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection.

This resolution expresses support for policies and other efforts to prevent childhood sunburns, such as exempting sunscreen from over-the-counter medication bans in schools.

Topics ✓ Healthcare

David P. Joyce (R) · 18 co-sponsors

in committee · Nebraska · House May 26, 2021

HR 3491: Stamp Out Lyme Disease Act

Stamp Out Lyme Disease Act This bill directs the U.S. Postal Service to issue a Lyme Disease Research Semipostal Stamp, with all proceeds being transferred to the National Institute of Allergy and Infectious Diseases.

Antonio Delgado (D) · 28 co-sponsors

in committee · Nebraska · House May 26, 2021

HR 3522: TREES Act of 2021

Trees for Residential Energy and Economic Savings Act of 2021 or the TREES Act of 2021 This bill directs the Department of Energy (DOE) to establish a grant program for states, local governments, Indian tribes, and other entities to facilitate tree planting projects that reduce residential energy consumption. Under the program, DOE may award grants to facilitate the planting of at least 300,000 trees annually in residential neighborhoods.

Topics ✓ Energy ✓ Environment

Doris O. Matsui (D) · 55 co-sponsors

in committee · Nebraska · House May 26, 2021

HR 3517: Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021

Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021 This bill specifies that certain Medicare payment rules applicable to imaging services shall apply to dual-energy x-ray absorptiometry services used in bone mass scans beginning in 2022. The Centers for Medicare & Medicaid Services must establish national minimum payment amounts for such services.

Topics ✓ Healthcare

John B. Larson (D) · 74 co-sponsors

in committee · Nebraska · House May 26, 2021

HR 3554: Pharmacy DIR Reform To Reduce Senior Drug Costs Act

Pharmacy DIR Reform To Reduce Senior Drug Costs Act This bill establishes certain requirements for prescription drug plans and the prices of covered drugs under the Medicare prescription drug benefit. Specifically, the bill requires price concessions, payments, and fees that are negotiated with a pharmacy to be included in a drug's negotiated price, excluding incentive payments, and for this price to be provided at the point of sale. Additionally, prescription drug plans must report price concessions or incentive payments that are made after payment for covered drugs at the point of sale, including by contracted intermediaries, to the pharmacy at least annually. The Centers for Medicare & Medicaid Services must establish standardized pharmacy performance measures with respect to incentive payments and price concessions; such measures must account for all pharmacy types, including specialty pharmacies, and focus on patient health outcomes and other targeted areas.

Peter Welch (D) · 64 co-sponsors

in committee · Nebraska · Senate May 25, 2021

S 1813: Accelerating Access to Critical Therapies for ALS Act

Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities to facilitate patients' access to investigational drugs that diagnose or treat ALS. The Food and Drug Administration (FDA) shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other severely debilitating neurodegenerative diseases. HHS shall also establish the Public-Private Partnership for Neurodegenerative Diseases between the National Institutes of Health, the FDA, and at least one eligible entity (generally, an institution of higher education or a nonprofit organization). The partnership shall support the development and regulatory review of drugs that address ALS and other rare neurodegenerative diseases. The FDA shall publish on its website a five-year action plan for fostering the development of drugs that improve or extend the lives of people living with rare neurodegenerative diseases.

Topics ✓ Healthcare

in committee · Nebraska · Senate May 25, 2021

S 1806: Biodiesel Tax Credit Extension Act of 2021

Biodiesel Tax Credit Extension Act of 2021 This bill extends the income and excise tax credits for biodiesel and renewable diesel used as fuel through 2025.

Topics ✓ Budget & Taxes ✓ Energy ✓ Environment ✓ Transportation

Chuck Grassley (R) · 17 co-sponsors